1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. - Wikidata - wikimedia - TriplyDB

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

http://www.wikidata.org/entity/Q33606850

about

Vitamin D for the treatment of inflammatory bowel disease Vitamin D and the skin: Focus on a complex relationship: A review Disrupted regulatory T cell homeostasis in inflammatory bowel diseases The Impact of Vitamin D Levels on Inflammatory Status: A Systematic Review of Immune Cell Studies Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D Vitamin D: link between osteoporosis, obesity, and diabetes?FOXO transcription factors throughout T cell biology Safety of engineered allergen-specific immunotherapy vaccines New vaccines for Mammalian allergy using molecular approaches Review article: vitamin D and inflammatory bowel disease--established concepts and future directions Immunotherapy with myeloid cells for tolerance induction Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease Vitamin D every day to keep the infection away?Vitamin D and inflammatory bowel disease Regulation of cathepsin G reduces the activation of proinsulin-reactive T cells from type 1 diabetes patients Vitamin D and the Pathogenesis of Inflammatory Bowel Disease.Vitamin D in hematological disorders and malignancies.The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.Vitamin D and the intracrinology of innate immunity.Canine Leishmaniasis Progression is Associated with Vitamin D Deficiency.The human health effects of ozone depletion and interactions with climate change.Vitamin D and inflammatory diseases.Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response Regulation of Mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin D3.Identification of novel immunoregulatory molecules in human thymic regulatory CD4+CD25+ T cells by phage display 1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2 Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?Seasonal variation in vitamin D₃ levels is paralleled by changes in the peripheral blood human T cell compartment.Vitamin D and mucosal immune function.Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression.Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells.Lipopolysaccharide-induced lung injury is independent of serum vitamin D concentration Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.Metabolic control of regulatory T cell development and function.Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells.

P2860

Q24186755-4CAC8850-52B0-4C79-846F-8CD88353F444 Q26773618-FB6664FE-EB7B-4F52-BD9E-8918DAAADE55 Q26774590-C17256A7-5EC3-4D93-B59B-BBAF7144A6E7 Q26777083-299641A0-925D-4BFA-9257-BC6BDCC65D98 Q26781318-02203C49-DD7E-4AB4-AFCF-A12B6C504156 Q26828851-A0ED6EA9-39BF-41F8-80BB-0365EA99C85D Q26853741-4BD6A7FE-FF45-4B15-9144-D0ABE5DFA5AD Q26860962-E82CC725-7FBC-49E0-B75E-BBA8E1629002 Q26998820-50C017AD-F56F-43C8-B40C-DCD66210C55E Q27015639-8A4B290E-24A4-458F-A4D7-688B7A853C63 Q27687406-16397D5A-C741-4392-A4F0-F81E072B2489 Q28069832-B950D63A-4C18-4A88-95AD-51B18EE31907 Q28081150-5855DDA5-80A6-44F5-A080-2257875DF06E Q28081172-A961AF2B-5194-4880-B970-D3E81F8BD3B5 Q28085484-1FC2A79D-AD15-43D5-9436-67B49CA13B39 Q28741728-7F5EDBDE-A7E0-4346-93E7-2B92C3379430 Q30248412-5CB20D6B-80D3-424E-A82C-3EF74CD92618 Q30275725-39F750C1-7A02-43EF-9416-60C38F8DB1E1 Q30388273-EE7FD33A-9F21-4D1F-BF4A-2006BCDDF42B Q33787809-4080C140-F4D0-43CC-A0F3-96EA319ECD8A Q33794111-5F6708B4-8415-46FC-A2DE-90B338BE4D65 Q33799335-3409603B-B791-44F3-ABAA-DAAD119368E0 Q33806322-590EDACC-BEF2-48D1-B2F3-580696C1A672 Q33948630-0BC397C4-A141-46A7-BA70-318AE556007F Q33955263-5861F1F3-2DF7-4880-B51E-ED4738EC0744 Q33988297-5C90A29F-9B2B-4381-B197-C34267753E8C Q34065797-72345FF7-0AB4-4F8C-BDF5-28BB8A799EC1 Q34123145-78CA8B87-78C0-4DAD-9433-157D51BE9DA0 Q34123604-C407541A-9A62-4B44-9982-E6E36D479FDC Q34204170-7DCE9210-A2EB-4A0C-A6F1-7100021C985B Q34287169-20AA814E-6480-4483-9818-8F5FA58BC549 Q34294390-CFE0E492-645F-4AE0-8EE5-41464FB48015 Q34346316-815B13E0-A5CE-438E-9DED-E76C3B993E1F Q34386094-971FB83C-5EB3-4ABC-A023-AB86BB5D0584 Q34489206-9321687D-3723-45A9-A3F4-EB382F228C06 Q34489841-3AC60EE6-4E64-48CB-831C-3896FED38D73 Q34550631-44EEAC85-EC97-4ECF-908B-1AF5AC4D6298 Q34621641-E2F44A6E-1850-41AD-BB83-8B20F527F1DA Q34790948-A172C7AF-ECC5-4ABC-9996-14629D29D48D Q35162343-5B4A5436-E5EA-4955-AA9B-236E1FB0DE8F

P2860

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

http://www.wikidata.org/entity/Q33606850

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

1,25-Dihydroxyvitamin D3 and I ...... s expressing CTLA-4 and FoxP3.

@ast

1,25-Dihydroxyvitamin D3 and I ...... s expressing CTLA-4 and FoxP3.

@en

type

label

1,25-Dihydroxyvitamin D3 and I ...... s expressing CTLA-4 and FoxP3.

@ast

1,25-Dihydroxyvitamin D3 and I ...... s expressing CTLA-4 and FoxP3.

@en

prefLabel

1,25-Dihydroxyvitamin D3 and I ...... s expressing CTLA-4 and FoxP3.

@ast

1,25-Dihydroxyvitamin D3 and I ...... s expressing CTLA-4 and FoxP3.

@en

P1433

Q33606850-11FE6FDB-4945-4137-BFD1-65505EF0127F

P1476

Q33606850-6FA4FAD0-C445-447D-B995-2B1E27A9FA4A

P2093

Q33606850-0961600A-B830-4812-9BDE-B0C72CBC6061

Q33606850-2A0E519E-38C0-4B9D-9333-F9D3105397DB

Q33606850-32412B84-1F9D-4D6F-933D-CC5E99DF1FF5

Q33606850-466A75FD-8923-471F-99EF-4D15BD613008

Q33606850-509EDC4B-E56D-4BA0-9570-DDA01412F7AB

Q33606850-6EA315F1-B015-4729-A8C3-3991B12123ED

Q33606850-B20D1BC6-0369-4313-B374-B97BA6AA3282

Q33606850-BFD0F831-5F1A-4392-9551-64DADC8B58D5

P2860

Q33606850-10BF26BB-737C-452F-9724-435C595EE7A3

Q33606850-1300A306-D1F6-4698-8843-79961FF8FD3C

Q33606850-182513FF-AB83-4B85-B080-FD37426E87FC

Q33606850-19A90805-7F5C-481B-A3B4-2F26ABE897E0

Q33606850-215955E0-FD3A-49B7-818E-62CD1B13A8B0

Q33606850-2267C16A-3E9B-4AF1-933B-D6C8E320901C

Q33606850-28FEFB66-9E1A-4EC3-A6BD-D204DAD405B2

Q33606850-2C2D4F46-9367-4C02-A195-CD8EA428CBBA

Q33606850-32C0DD61-1686-45C0-8FEF-3DBC6B5E4826

Q33606850-34C5D3B7-A20B-4958-AFF4-CA3145EAA7B2

P304

Q33606850-CB5D4564-13FF-4F8A-BA94-E3C9364813C2

P31

Q33606850-2B75F35A-1265-4CB2-94C1-823E385593D7

P356

Q33606850-A441C0DB-E39B-415E-A3EA-3BC934361598

P407

Q33606850-7EE95132-BB50-4753-A36F-6229DB840C6A

P433

Q33606850-43F36560-A462-47D4-9205-C26CA7D9778D

P478

Q33606850-0A258B22-E8DE-44BB-89CD-2CAAD4AD9E25

P50

Q33606850-01C76AD2-4F11-4B15-ACED-27F278B42DED

Q33606850-069D5D86-4093-4022-A2B0-90BA03F98D24

P577

Q33606850-4A779CF3-6309-4FD7-970B-20C9A5B285C7

P5875

Q33606850-9BFE111E-3B42-4C7F-A89D-A1E4366D5B39

P698

Q33606850-75F090C3-7E15-4893-9849-B93E16B71777

P932

Q33606850-1F2BBCE9-2EEB-41DF-86C4-64B33F3B353D

P356

JIMMUNOL.0803217

P1433

Journal of Immunology

P1476

1,25-Dihydroxyvitamin D3 and I ...... ls expressing CTLA-4 and FoxP3

@en

P2093

David A Lammas

http://www.w3.org/2001/XMLSchema#string

Fiona Burke

http://www.w3.org/2001/XMLSchema#string

Karim Raza

http://www.w3.org/2001/XMLSchema#string

Louisa E Jeffery

http://www.w3.org/2001/XMLSchema#string

Manuela Mura

http://www.w3.org/2001/XMLSchema#string

Martin Hewison

http://www.w3.org/2001/XMLSchema#string

Omar S Qureshi

http://www.w3.org/2001/XMLSchema#string

Yong Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells

Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Vitamin D deficiency

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA

P304

5458-5467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0803217

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38024906

http://www.w3.org/2001/XMLSchema#string

P698

19843932

http://www.w3.org/2001/XMLSchema#string

P932

2810518

http://www.w3.org/2001/XMLSchema#string